Determinant in human immunodeficiency virus type 1 for efficient replication under cytokine-induced CD4(+) T-helper 1 (Th1)- and Th2-type conditions.
about
Selective transmission of R5 HIV-1 over X4 HIV-1 at the dendritic cell-T cell infectious synapse is determined by the T cell activation state.Envelope-dependent restriction of human immunodeficiency virus type 1 spreading in CD4(+) T lymphocytes: R5 but not X4 viruses replicate in the absence of T-cell receptor restimulationHIV-1 competition experiments in humanized mice show that APOBEC3H imposes selective pressure and promotes virus adaptationOX40 stimulation by gp34/OX40 ligand enhances productive human immunodeficiency virus type 1 infection.APOBEC3D and APOBEC3F potently promote HIV-1 diversification and evolution in humanized mouse model.A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activityIncreased levels of circulating cytokines with HIV-related immunosuppression.Modulation of human immunodeficiency virus type 1 infectivity through incorporation of tetraspanin proteins.APOBEC3G and APOBEC3F Act in Concert To Extinguish HIV-1 ReplicationChemokine-receptor activation by env determines the mechanism of death in HIV-infected and uninfected T lymphocytes.Induction of protective immune responses against R5 human immunodeficiency virus type 1 (HIV-1) infection in hu-PBL-SCID mice by intrasplenic immunization with HIV-1-pulsed dendritic cells: possible involvement of a novel factor of human CD4(+) T-ceDifferential effects of HIV transmission from monocyte-derived dendritic cells vs. monocytes to IL-17+CD4+ T cells.Host factor transcriptional regulation contributes to preferential expression of HIV type 1 in IL-4-producing CD4 T cellsExperimental adaptive evolution of SIVcpz to pandemic HIV-1 using a humanized mouse model.Broad-spectrum antiviral agents: secreted phospholipase A2 targets viral envelope lipid bilayers derived from the endoplasmic reticulum membrane.
P2860
Q33404066-86A76965-36BB-48F5-8886-3A787DC7C59FQ33649801-18023993-2A36-42C8-9669-897D76CCCA51Q33699581-AC244442-0F57-4C9D-BF14-7446B87CA1E4Q33844046-584DE750-DC07-491F-9F81-A45E4F2C5D51Q34352429-D19CA364-82CF-499B-80F8-A3C0B7B5F25AQ34955359-963D8576-A05F-412B-87E8-CAAA92ADED87Q36102520-B0211563-AA9C-4259-AB27-829CA02D080FQ36424527-F03A0715-D828-4D74-8A31-91F4A3BADE93Q36811931-9C2D6EF6-47C5-4D63-AFCA-ED8F2F522468Q39563512-85E0463A-5989-4194-A7ED-93A087E9C00FQ39796585-59832211-88C6-403C-A848-D485618199D1Q40573003-8ED648BE-7253-4049-9ABC-12C16EB32133Q42324067-6A804F82-71D0-43F2-B8A4-C7C33CD12A79Q46246548-B59D24F2-EF74-4980-AE1D-AF34D52D481EQ47129913-ACC96B5E-8064-40E4-8BA7-74F00604CF6F
P2860
Determinant in human immunodeficiency virus type 1 for efficient replication under cytokine-induced CD4(+) T-helper 1 (Th1)- and Th2-type conditions.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Determinant in human immunodef ...... ion under cytokine-induced CD4
@nl
Determinant in human immunodef ...... Th1)- and Th2-type conditions.
@en
type
label
Determinant in human immunodef ...... ion under cytokine-induced CD4
@nl
Determinant in human immunodef ...... Th1)- and Th2-type conditions.
@en
prefLabel
Determinant in human immunodef ...... ion under cytokine-induced CD4
@nl
Determinant in human immunodef ...... Th1)- and Th2-type conditions.
@en
P2093
P2860
P1433
P1476
Determinant in human immunodef ...... (Th1)- and Th2-type conditions
@en
P2093
N Yamamoto
T Murakami
W A O'Brien
Y Koyanagi
P2860
P304
P407
P577
1999-01-01T00:00:00Z